EDE (ASX) Ann: Investor Presentation

Originally posted by Crystaltrade: ↑

Continued reply to repeated 'claims' on this forum;

Marketing study was abandoned.

This was the study's announcement;

Key Marketing Study Commenced
Eden has commissioned one of the world’s top management companies to undertake a detailed marketing study of both the US and the global concrete markets and to assist Eden in the preparation of a comprehensive EdenCreteTM marketing plan.
The global concrete market is a huge, multi-faceted industry, the structure and key players of which vary from country to country. In order to develop a cohesive marketing plan, detailed market knowledge is necessary, including details of the size, market sectors and structure of the market in each country, together with the details of the key admixture suppliers in each market.
The two stage marketing study has commenced and is anticipated to be completed within the next 8-10 weeks.

AUSTRALIAN SECURITIES EXCHANGE ANNOUNCEMENT
16 June 2016
EDENCRETE TM UPDATE

It was mentioned again 2 weeks later as continuing.

This notion of abandonment was decided upon based on the fact it was not released. Why would it be? This was paid for commercially sensitive information. Why would they release it for competitors to take advantage of? But the usage of the completed study is peppered throughout subsequent announcements.

3 months later the name was changed from Eden Energy to Eden Innovations. Statistics such as US bridge spending, disrepair etc. India's flyash usage and costings. Opening markets such as DoTs with NTPEP testing. First order free and lab support. Australian distributorship. The list goes on. Fake news.

No comparison of apple to apple products available.

There aren't any directly comparable products. Period. To cover the range of attributes EdenCrete confers, multiple existing products are needed.

Some posters like to say things like "just add more cement" or "oh, look at this sealant by Sika" or "if it worked, one of the big boys would already be selling it".

The plethora of additives on the market show there is a need for products that facilitate concrete improvement of various attributes.

ASTM testing is the industry standard for comparison. It is there for the express purpose that a customer trying to make a decision between say, metal fibres or EdenCrete for their warehouse floor has a direct reference between the 2 and can then make an informed decision after taking in other factors such as price (materials, prep, labour costs etc.) and specifications.

The other avenue to compare products is trialing. An example of this shotcrete. The usual additive is plasticier. Through their growing connections EDE convinced the contractors doing the C-70 job for CDoT to trial Edencrete instead. The rest, as they say, is history. The shotcreters rave about EdenCrete and the multitude of extra benefits received for the same price and that 'word of mouth' advertising is spreading quickly. Since they began we now have 6 shotcreters across 2 states using EdenCrete regularly with growing interest in that market and the adjacent area of 'pumpability' as well.

IMO DYOR GLTS

Expand

Just gotta wonder, whether some of the posters here may be the competition. The admixture business is fierce and Edencrete could easily replace some of the existing products as it is a multifunctional product.

No.	Vol.	Price($)
80	221115832	0.1¢

No.

Vol.

Price($)

221115832

0.1¢

Price($)	Vol.	No.
0.2¢	9899800	11

Price($)

Vol.

No.

0.2¢

9899800

No.	Vol.	Price($)
80	221115832	0.001
0	0	0.000
0	0	0.000
0	0	0.000
0	0	0.000

No.

Vol.

Price($)

221115832

0.001

0.000

Price($)	Vol.	No.
0.002	9899800	11
0.003	51073595	27
0.004	8849367	7
0.005	360000	1
0.006	2831956	1

Price($)

Vol.

No.

0.002

9899800

0.003

51073595

0.004

8849367

0.005

360000

0.006

2831956

(20min delay)
Last 0.2¢		Change 0.000(0.00%)		Mkt cap ! $7.427M

Open	High	Low	Value	Volume
0.1¢	0.2¢	0.1¢	$108	79.00K

Ann: Investor Presentation, page-79

AI stocks: What to expect in 2024-25

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Investor Presentation, page-79

Top Stories

AI stocks: What to expect in 2024-25

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News